August 23, 2025International Journal of Molecular SciencesOpen Access

High-Sensitivity Troponins and Homocysteine: Combined Biomarkers for Better Prediction of Cardiovascular Events

View Full Paper

Ask AI

Bookmark

Authors

DDDragan M. DjuricUniversity of Banja Luka ZBZorislava BajićUniversity of Banja Luka NRNina M. RadisavljevicUniversity of Belgrade

Discussion

Member takes

Implication

This review demonstrates that combining high-sensitivity cardiac troponins and homocysteine may enhance cardiovascular risk prediction, suggesting new strategies for assessment and treatment.

Key Points

Combining high-sensitivity troponins and homocysteine improves cardiovascular risk prediction, highlighting their complementary roles.
Emerging evidence shows significant correlations between elevated homocysteine and troponins, indicating potential clinical value.
This comprehensive review examines the shared mechanisms of myocardial injury and vascular dysfunction through biomarker assessment.
Further studies are essential to validate this combined marker approach for effective population-specific risk management.

Cite This Study

Djurić et al. (2025) studied this question.

synapsesocial.com/papers/68af79a47567bf4f94ff169b https://doi.org/10.3390/ijms26178186

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates that combining high-sensitivity cardiac troponins and homocysteine may enhance cardiovascular risk prediction, suggesting new strategies for assessment and treatment.